Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -7.17 | 40.66 |
PEG Ratio (TTM) | -0.44 | 5.42 |
P/S Ratio (TTM) | 3.02 | 6.33 |
P/B Ratio (TTM) | 21.69 | 5.87 |
P/FCF Ratio (TTM) | -12.55 | 37.81 |
Price to 5YR AVG Earnings Ratio | N/A | 59.41 |
Price to 5YR AVG FCF Ratio | N/A | 36.98 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -31.67% | 4.66% |
ROE (TTM) | -195.26% | 25.49% |
Net Profit Margin (TTM) | -41.63% | 7.22% |
ROIC 5YR AVG | N/A | 6.54% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 4.93% | -10.24% | N/A |
Revenue | 4.00% | 7.28% | N/A |
Net Income | 1.72% | -11.43% | N/A |
Cash Flow | -18.77% | -16.70% | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.37 | 2.64 |
Quick Ratio (TTM) | 5.47 | 1.97 |
D/E Ratio (TTM) | 6.15 | 0.55 |
Interest Coverage (TTM) | -2.80 | 2.38 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | N/A | 7.18 |
LTL to 5YR AVG FCF | N/A | 3.69 |
Shares Outstanding Growth 5YR AVG | N/A | 1.65% |